For neovascular AMD monitoring , the average recurrence to treatment time was shorter for the routine group ( 0.04 days ) compared with 13.6 days for the teleophthalmologic group , for a difference of -13.5 days ( 95 % CI , -18.2 to -9.0 days ; P < .01 ) .